Chagas-Paula performed all of the tests with this scholarly research and wrote the manuscript

This metabolic liability was prevented by replacing the piperazine ring with piperidine, an approach that contributed to the discovery of ceritinib, an ALK inhibitor approved by the FDA to treat small cell lung cancer